BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Presbia Announces the Appointment of Jake Vander Zanden as Chief Commercial Officer


2/19/2013 9:49:24 AM

IRVINE, Calif.--(BUSINESS WIRE)--Presbia, a medical device company and leader in near vision restoration, announced today the appointment of Jake Vander Zanden as Chief Commercial Officer. Bringing more than 25 years of experience in the healthcare industry, Mr. Vander Zanden will be responsible for expanding the commercial growth of the Presbia Flexivue Microlens™, the company’s implantable corneal inlay solution for presbyopia, the age-related loss of near vision. “Jake’s extensive experience in the ophthalmology space will be extremely valuable to Presbia as we continue to ramp up our efforts to grow the commercial availability of the Presbia Flexivue Microlens™ outside of the United States,” said Zohar Loshitzer, Chief Executive Officer of Presbia. “By adding top talent and resources to these efforts, we hope to be able to accelerate market availability of our innovative solution for the correction of near vision loss to an even greater number of patients.”

Read at BioSpace.com

Presbia
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES